0000892251-23-000068.txt : 20230608
0000892251-23-000068.hdr.sgml : 20230608
20230608161533
ACCESSION NUMBER: 0000892251-23-000068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230606
FILED AS OF DATE: 20230608
DATE AS OF CHANGE: 20230608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Medpace Investors, LLC
CENTRAL INDEX KEY: 0001524599
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37856
FILM NUMBER: 231002093
BUSINESS ADDRESS:
STREET 1: 4620 WESLEY AVENUE
CITY: CINCINNATI
STATE: OH
ZIP: 45212
BUSINESS PHONE: 513-579-9911
MAIL ADDRESS:
STREET 1: 4620 WESLEY AVENUE
CITY: CINCINNATI
STATE: OH
ZIP: 45212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medpace Holdings, Inc.
CENTRAL INDEX KEY: 0001668397
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 320434904
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
BUSINESS PHONE: (513) 579-9911
MAIL ADDRESS:
STREET 1: 5375 MEDPACE WAY
CITY: CINCINNATI
STATE: OH
ZIP: 45227
4
1
form4.xml
X0407
4
2023-06-06
0001668397
Medpace Holdings, Inc.
MEDP
0001524599
Medpace Investors, LLC
C/O MEDPACE HOLDINGS, INC.
5375 MEDPACE WAY
CINCINNATI
OH
45227
true
true
Common Stock
2023-06-06
4
S
0
58681
220.46
D
6392690
D
Common Stock
2023-06-07
4
S
0
110324
223.05
D
6282366
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2023.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $221.75. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $220.00 to $226.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
/s/ Stephen P. Ewald, Authorized Signatory for Medpace Investors, LLC
2023-06-08